rs61754024
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 5P and 6B. PM1PM5PP3BP4_ModerateBS2
The NM_000350.3(ABCA4):c.1928T>G(p.Val643Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00256 in 1,613,566 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V643M) has been classified as Likely benign.
Frequency
Consequence
NM_000350.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABCA4 | NM_000350.3 | c.1928T>G | p.Val643Gly | missense_variant | 13/50 | ENST00000370225.4 | NP_000341.2 | |
ABCA4 | XM_047416704.1 | c.1928T>G | p.Val643Gly | missense_variant | 13/49 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCA4 | ENST00000370225.4 | c.1928T>G | p.Val643Gly | missense_variant | 13/50 | 1 | NM_000350.3 | ENSP00000359245.3 | ||
ABCA4 | ENST00000649773.1 | c.1928T>G | p.Val643Gly | missense_variant | 13/19 | ENSP00000496882.1 |
Frequencies
GnomAD3 genomes AF: 0.00168 AC: 256AN: 152046Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.00155 AC: 389AN: 251136Hom.: 1 AF XY: 0.00161 AC XY: 219AN XY: 135716
GnomAD4 exome AF: 0.00265 AC: 3880AN: 1461404Hom.: 7 Cov.: 37 AF XY: 0.00257 AC XY: 1868AN XY: 727000
GnomAD4 genome AF: 0.00168 AC: 256AN: 152162Hom.: 2 Cov.: 32 AF XY: 0.00142 AC XY: 106AN XY: 74402
ClinVar
Submissions by phenotype
not provided Uncertain:4Benign:1Other:1
not provided, no classification provided | literature only | Retina International | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 15, 2023 | Identified previously in other individual with features of an ABCA4-related disorder; however, the variant was either reported in the heterozygous state, or was seen with a second ABCA4 variant, phase unknown, whose pathogenicity was not established (Allikmets et al., 1997; Sciezynska et al., 2015; Rosenberg et al., 2007; Birtel et al., 2018; Sergouniotis et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 20981092, 27628848, 24265693, 17982420, 26593885, 29555955, 34426522, Scott2022[CaseReport], 34513887, 31429209, 32531858, 9295268) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 01, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 09, 2023 | The ABCA4 c.1928T>G; p.Val643Gly variant (rs61754024) is reported in the medical literature in individuals with retinopathy in the heterozygous state without an additional pathogenic ABCA4 variant (Birtel 2018, Rosenberg 2007, Scienzynska 2016) and was originally described at a similar frequency in affected and unaffected individuals (Allikmets 1997). The variant is reported in the ClinVar database (Variation ID: 99102) and in the European (non-Finnish) population with an overall allele frequency of 0.3% (389/128892 alleles including 1 homozygote) in the Genome Aggregation Database. The valine at this position is highly conserve but computational analyses (SIFT: Damaging, PolyPhen-2: Benign) predict conflicting effects of this variant on protein structure/function. Due to limited information, the clinical significance of the variant is uncertain at this time. References: Allikmets R et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science. 1997 Sep 19;277(5333):1805-7. Birtel J et al. Clinical and genetic characteristics of 251 consecutive patients with macular and cone/cone-rod dystrophy. Sci Rep. 2018 Mar 19;8(1):4824 Rosenberg T et al. N965S is a common ABCA4 variant in Stargardt-related retinopathies in the Danish population. Mol Vis. 2007 Oct 17;13:1962-9. Sciezynska A et al. Next-generation sequencing of ABCA4: High frequency of complex alleles and novel mutations in patients with retinal dystrophies from Central Europe. Exp Eye Res. 2016 Apr;145:93-99. - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | ABCA4: PM3, PM2:Supporting - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
ABCA4-related disorder Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 10, 2024 | The ABCA4 c.1928T>G variant is predicted to result in the amino acid substitution p.Val643Gly. This variant has been reported in cohort studies of retinal disease, but in several cases a second ABCA4 variant was not detected or a variant in a different gene was found to be causative (Rosenberg et al. 2007. PubMed ID: 17982420; Kitiratschky et al. 2008. PubMed ID: 18285826; Maia-Lopes et al. 2009. PubMed ID: 19365591; Eisenberger et al. 2013. PubMed ID: 24265693). This variant has also been reported in the heterozygous state in individuals with age related macular degeneration (Allikmets et al. 1997. PubMed ID: 9295268; Fritsche et al. 2012. PubMed ID: 22427542). This variant is reported in 0.30% of alleles in individuals of European (Non-Finnish) descent in gnomAD, including 9 homozygous individuals in gnomAD v4.1.0 (https://gnomad.broadinstitute.org/variant/1-94062586-A-C?dataset=gnomad_r4). This variant has conflicting interpretations in ClinVar ranging from likely pathogenic to likely benign (https://www.ncbi.nlm.nih.gov/clinvar/variation/99102/). Given the conflicting evidence, at this time, the clinical significance of this variant is uncertain. - |
Retinal dystrophy Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Blueprint Genetics | Feb 19, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg | Jan 01, 2023 | - - |
Severe early-childhood-onset retinal dystrophy Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Ocular Genomics Institute, Massachusetts Eye and Ear | Apr 08, 2021 | The ABCA4 c.1928T>G variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PP3. Based on this evidence we have classified this variant as Variant of Uncertain Significance. - |
Cone-rod dystrophy 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen | Sep 24, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at